Cargando…
Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double‐blind, randomized, placebo‐controlled trial
AIM: The aim of this study was to explore the effectiveness and safety of pentoxifylline as an adjuvant to risperidone in mitigating the negative symptoms in patients with chronic schizophrenia. METHODS: In this randomized, placebo‐controlled study, eighty outpatients with chronic schizophrenia were...
Autores principales: | Abdallah, Mahmoud S., Mosalam, Esraa M., Hassan, Ahmed, Ramadan, Ahmed N., Omara‐Reda, Hend, Zidan, Abdel‐Aziz A., Samman, Waad A., El‐berri, Eman I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804082/ https://www.ncbi.nlm.nih.gov/pubmed/36341700 http://dx.doi.org/10.1111/cns.14010 |
Ejemplares similares
-
Double‐blind, randomized, placebo‐controlled pilot study of the phosphodiesterase‐3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder
por: Abdallah, Mahmoud S., et al.
Publicado: (2021) -
The Potential Neuroprotective Effect of Thymoquinone on Scopolamine-Induced In Vivo Alzheimer’s Disease-like Condition: Mechanistic Insights
por: Abo Mansour, Hend E., et al.
Publicado: (2023) -
Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial
por: El-Khateeb, Eman, et al.
Publicado: (2023) -
Pentoxifylline as an adjunct therapy in children with cerebral malaria
por: Lell, Bertrand, et al.
Publicado: (2010) -
Pentoxifylline in severe sepsis: a double-blind, randomized placebo-controlled study
por: Staubach, KH, et al.
Publicado: (1998)